

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.58607285 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.20467122 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11535713 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.11535713 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.11133371 |
| 6 | positive regulation of granulocyte differentiation (GO:0030854) | 4.93746287 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.85008538 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.83697738 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.78318065 |
| 10 | negative T cell selection (GO:0043383) | 4.71685216 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45336345 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.37073158 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19389694 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17664968 |
| 15 | response to interleukin-15 (GO:0070672) | 3.97357051 |
| 16 | positive T cell selection (GO:0043368) | 3.87424841 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 3.79846580 |
| 18 | positive thymic T cell selection (GO:0045059) | 3.78478623 |
| 19 | cellular response to ethanol (GO:0071361) | 3.69602076 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.69184953 |
| 21 | interferon-gamma production (GO:0032609) | 3.68812220 |
| 22 | mannose metabolic process (GO:0006013) | 3.63959575 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.63899519 |
| 24 | tolerance induction (GO:0002507) | 3.63587126 |
| 25 | activated T cell proliferation (GO:0050798) | 3.60326718 |
| 26 | embryonic process involved in female pregnancy (GO:0060136) | 3.59117988 |
| 27 | histone H3-K4 trimethylation (GO:0080182) | 3.56486036 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.53544869 |
| 29 | cellular extravasation (GO:0045123) | 3.52103020 |
| 30 | T cell migration (GO:0072678) | 3.49171511 |
| 31 | T cell selection (GO:0045058) | 3.48345826 |
| 32 | regulation of histone H3-K27 methylation (GO:0061085) | 3.36721275 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33046520 |
| 34 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.30328837 |
| 35 | regulation of granulocyte differentiation (GO:0030852) | 3.30188311 |
| 36 | detection of other organism (GO:0098543) | 3.26773577 |
| 37 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.26684709 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.25399244 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.24335631 |
| 40 | leukocyte aggregation (GO:0070486) | 3.23895964 |
| 41 | thymic T cell selection (GO:0045061) | 3.23635158 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.22469506 |
| 43 | regulation of B cell differentiation (GO:0045577) | 3.17123641 |
| 44 | phospholipid scrambling (GO:0017121) | 3.15750630 |
| 45 | mature B cell differentiation (GO:0002335) | 3.15278873 |
| 46 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13965441 |
| 47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.10809761 |
| 48 | detection of bacterium (GO:0016045) | 3.06433768 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.01866923 |
| 50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98777534 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 2.97480515 |
| 52 | histone H3-K9 modification (GO:0061647) | 2.96380868 |
| 53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96062114 |
| 54 | B cell homeostasis (GO:0001782) | 2.95943420 |
| 55 | mature B cell differentiation involved in immune response (GO:0002313) | 2.93553973 |
| 56 | histone H3-K36 demethylation (GO:0070544) | 2.93042960 |
| 57 | germinal center formation (GO:0002467) | 2.93001624 |
| 58 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.85917793 |
| 59 | Peyers patch development (GO:0048541) | 2.85917793 |
| 60 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.84722310 |
| 61 | T cell homeostasis (GO:0043029) | 2.82238435 |
| 62 | histone H3-K9 demethylation (GO:0033169) | 2.82003595 |
| 63 | regulation of necroptotic process (GO:0060544) | 2.81933548 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80885623 |
| 65 | regulation of tolerance induction (GO:0002643) | 2.80808376 |
| 66 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.80015942 |
| 67 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.79752234 |
| 68 | dendritic cell chemotaxis (GO:0002407) | 2.79500674 |
| 69 | detection of external biotic stimulus (GO:0098581) | 2.71275036 |
| 70 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69929670 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69929670 |
| 72 | dendritic cell migration (GO:0036336) | 2.69445456 |
| 73 | lymphocyte homeostasis (GO:0002260) | 2.69385424 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 2.69208937 |
| 75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68309809 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68167396 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68167396 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68167396 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.68167396 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68167396 |
| 81 | modulation by symbiont of host defense response (GO:0052031) | 2.68167396 |
| 82 | alpha-beta T cell differentiation (GO:0046632) | 2.68112992 |
| 83 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.66600515 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66571140 |
| 85 | natural killer cell differentiation (GO:0001779) | 2.65601873 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65569412 |
| 87 | positive regulation of tolerance induction (GO:0002645) | 2.65466259 |
| 88 | T cell receptor signaling pathway (GO:0050852) | 2.65435060 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 2.63768212 |
| 90 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.63730874 |
| 91 | dosage compensation (GO:0007549) | 2.63722758 |
| 92 | macrophage activation involved in immune response (GO:0002281) | 2.62980170 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 2.62931873 |
| 94 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62194446 |
| 95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62194446 |
| 96 | interkinetic nuclear migration (GO:0022027) | 2.59324038 |
| 97 | peptidyl-lysine trimethylation (GO:0018023) | 2.57066780 |
| 98 | histone H3-K9 methylation (GO:0051567) | 2.56126161 |
| 99 | neutrophil activation (GO:0042119) | 2.55283860 |
| 100 | alpha-beta T cell activation (GO:0046631) | 2.53957899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.82179534 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89315273 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.89053858 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.26365715 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.20863075 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.06109901 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03231166 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90866180 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85807065 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 2.68523564 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67970456 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57357548 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.55993520 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48577248 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42145904 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41536633 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38615363 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.23753873 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.23000002 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10840865 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09446796 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01267299 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.97966020 |
| 24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.97414974 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94839088 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89972860 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.86208345 |
| 28 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.82467329 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73529829 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.73158462 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70509098 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.70462612 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67535524 |
| 34 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.58945293 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57409431 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56021739 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.53267911 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53252583 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52392364 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50721110 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47749980 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43374442 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.41088919 |
| 44 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38692614 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38171810 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37734617 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37329332 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37253647 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35757949 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32480663 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31902873 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30287093 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25008556 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24371014 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21059260 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20741123 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.18317744 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13280500 |
| 59 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11624466 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11141594 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10663012 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10514163 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07205076 |
| 64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06686057 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.06622799 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01472708 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00920713 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00745846 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99012680 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97211641 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97200550 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96762877 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95383812 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92241318 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90559476 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90396050 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90396021 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89814588 |
| 79 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87818869 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86809595 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86391077 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84150083 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83782182 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83592716 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83564691 |
| 86 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.83348230 |
| 87 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82450259 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82221560 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81846482 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81030744 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80829910 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80705727 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79863086 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78189162 |
| 95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78100303 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77298500 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77077529 |
| 98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77021212 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.75892679 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75803200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.78368088 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.53515982 |
| 3 | MP0003436_decreased_susceptibility_to | 3.39799828 |
| 4 | MP0003724_increased_susceptibility_to | 3.14846177 |
| 5 | MP0001800_abnormal_humoral_immune | 3.12463135 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.09553863 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.99456672 |
| 8 | MP0002009_preneoplasia | 2.94978090 |
| 9 | MP0005671_abnormal_response_to | 2.83592646 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.70553864 |
| 11 | MP0000685_abnormal_immune_system | 2.61273085 |
| 12 | MP0002723_abnormal_immune_serum | 2.45289986 |
| 13 | MP0005387_immune_system_phenotype | 2.41316405 |
| 14 | MP0001790_abnormal_immune_system | 2.41316405 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.37463829 |
| 16 | MP0002419_abnormal_innate_immunity | 2.34617533 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.33968634 |
| 18 | MP0001819_abnormal_immune_cell | 2.31574804 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.30213069 |
| 20 | MP0008057_abnormal_DNA_replication | 2.27235221 |
| 21 | MP0003828_pulmonary_edema | 2.15351076 |
| 22 | MP0005025_abnormal_response_to | 2.13467325 |
| 23 | MP0002398_abnormal_bone_marrow | 2.12755293 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 2.06868639 |
| 25 | MP0002405_respiratory_system_inflammati | 2.02968661 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.00527313 |
| 27 | MP0003303_peritoneal_inflammation | 1.96958314 |
| 28 | MP0000716_abnormal_immune_system | 1.93724852 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.89477877 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.88575664 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.84325011 |
| 32 | MP0004947_skin_inflammation | 1.83781673 |
| 33 | MP0009785_altered_susceptibility_to | 1.80948813 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.78898864 |
| 35 | MP0002722_abnormal_immune_system | 1.78009903 |
| 36 | MP0003866_abnormal_defecation | 1.77518295 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.71675356 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.69130432 |
| 39 | MP0006082_CNS_inflammation | 1.66713067 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.61216074 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.53924324 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.52612753 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.50394713 |
| 44 | MP0002429_abnormal_blood_cell | 1.49696752 |
| 45 | MP0001851_eye_inflammation | 1.46791969 |
| 46 | MP0003091_abnormal_cell_migration | 1.42101544 |
| 47 | MP0003045_fibrosis | 1.40996268 |
| 48 | MP0004883_abnormal_blood_vessel | 1.37227051 |
| 49 | MP0006054_spinal_hemorrhage | 1.35559068 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.34409570 |
| 51 | MP0002933_joint_inflammation | 1.34124387 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.34091918 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.33612731 |
| 54 | MP0009278_abnormal_bone_marrow | 1.23738460 |
| 55 | MP0003690_abnormal_glial_cell | 1.23211453 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.19642671 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.19642671 |
| 58 | MP0001853_heart_inflammation | 1.19028464 |
| 59 | MP0003252_abnormal_bile_duct | 1.18436915 |
| 60 | MP0004381_abnormal_hair_follicle | 1.08000574 |
| 61 | MP0005310_abnormal_salivary_gland | 1.04430857 |
| 62 | MP0005164_abnormal_response_to | 1.04177085 |
| 63 | MP0009115_abnormal_fat_cell | 1.03388925 |
| 64 | MP0005451_abnormal_body_composition | 1.03363061 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.01231360 |
| 66 | MP0008260_abnormal_autophagy | 1.00711714 |
| 67 | MP0004130_abnormal_muscle_cell | 0.98754121 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 0.96651979 |
| 69 | MP0008469_abnormal_protein_level | 0.95639823 |
| 70 | MP0002006_tumorigenesis | 0.94126890 |
| 71 | MP0001873_stomach_inflammation | 0.92135114 |
| 72 | MP0009764_decreased_sensitivity_to | 0.85734292 |
| 73 | MP0009763_increased_sensitivity_to | 0.81589069 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.81444006 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.79581776 |
| 76 | MP0000604_amyloidosis | 0.77335334 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.77117790 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.75897122 |
| 79 | MP0001958_emphysema | 0.75380563 |
| 80 | MP0000858_altered_metastatic_potential | 0.75286347 |
| 81 | MP0000249_abnormal_blood_vessel | 0.72528599 |
| 82 | MP0005360_urolithiasis | 0.72000459 |
| 83 | MP0003795_abnormal_bone_structure | 0.71606701 |
| 84 | MP0002133_abnormal_respiratory_system | 0.69916740 |
| 85 | MP0005388_respiratory_system_phenotype | 0.69916740 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69385446 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.68400502 |
| 88 | MP0001915_intracranial_hemorrhage | 0.66268305 |
| 89 | MP0003868_abnormal_feces_composition | 0.66061967 |
| 90 | MP0010307_abnormal_tumor_latency | 0.65352796 |
| 91 | MP0000371_diluted_coat_color | 0.64836572 |
| 92 | MP0005621_abnormal_cell_physiology | 0.62201193 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.62051445 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.59755652 |
| 95 | MP0002971_abnormal_brown_adipose | 0.57656014 |
| 96 | MP0003448_altered_tumor_morphology | 0.56716615 |
| 97 | MP0002928_abnormal_bile_duct | 0.56181126 |
| 98 | MP0008995_early_reproductive_senescence | 0.55755566 |
| 99 | MP0002168_other_aberrant_phenotype | 0.55297919 |
| 100 | MP0002132_abnormal_respiratory_system | 0.55077514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.15299411 |
| 2 | T lymphocytopenia (HP:0005403) | 4.60511616 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.21029713 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.97169983 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.66639205 |
| 6 | Myositis (HP:0100614) | 3.61932813 |
| 7 | Spontaneous hematomas (HP:0007420) | 3.55658814 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.53250287 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.46952550 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 3.27405904 |
| 11 | Increased IgE level (HP:0003212) | 3.26030654 |
| 12 | Recurrent viral infections (HP:0004429) | 3.25853626 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.21241972 |
| 14 | Pustule (HP:0200039) | 3.19221439 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.16341935 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14482725 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14482725 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13108812 |
| 19 | Colitis (HP:0002583) | 3.11481107 |
| 20 | Abnormality of T cells (HP:0002843) | 3.09757997 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.07504451 |
| 22 | Optic neuritis (HP:0100653) | 3.01146628 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.01146628 |
| 24 | Gingivitis (HP:0000230) | 3.00097201 |
| 25 | Pulmonary infiltrates (HP:0002113) | 2.99855273 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 2.87395606 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.86116921 |
| 28 | Inflammation of the large intestine (HP:0002037) | 2.85691298 |
| 29 | Orchitis (HP:0100796) | 2.81258054 |
| 30 | Granulocytopenia (HP:0001913) | 2.79784925 |
| 31 | Leukocytosis (HP:0001974) | 2.71861672 |
| 32 | Recurrent skin infections (HP:0001581) | 2.71764762 |
| 33 | Meningitis (HP:0001287) | 2.71602502 |
| 34 | Recurrent bronchitis (HP:0002837) | 2.70847706 |
| 35 | Epistaxis (HP:0000421) | 2.70683980 |
| 36 | Stomatitis (HP:0010280) | 2.70646128 |
| 37 | Vasculitis (HP:0002633) | 2.67960106 |
| 38 | Papilledema (HP:0001085) | 2.66421452 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.64009438 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 2.58332824 |
| 41 | IgG deficiency (HP:0004315) | 2.48929516 |
| 42 | Abnormality of eosinophils (HP:0001879) | 2.45873924 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.44776639 |
| 44 | Eosinophilia (HP:0001880) | 2.43829236 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.42691055 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.42508488 |
| 47 | Chest pain (HP:0100749) | 2.41865538 |
| 48 | Gingival bleeding (HP:0000225) | 2.40027763 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.39671253 |
| 50 | Chronic diarrhea (HP:0002028) | 2.39089306 |
| 51 | Encephalitis (HP:0002383) | 2.36803367 |
| 52 | Fatigue (HP:0012378) | 2.35142994 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.33962797 |
| 54 | Combined immunodeficiency (HP:0005387) | 2.31802360 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.30478847 |
| 56 | Hematochezia (HP:0002573) | 2.30348972 |
| 57 | Hemoptysis (HP:0002105) | 2.30224131 |
| 58 | IgM deficiency (HP:0002850) | 2.29896625 |
| 59 | Viral hepatitis (HP:0006562) | 2.29879040 |
| 60 | Lymphopenia (HP:0001888) | 2.22117619 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.20188017 |
| 62 | Spinal cord lesions (HP:0100561) | 2.18562488 |
| 63 | Syringomyelia (HP:0003396) | 2.18562488 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.17940730 |
| 65 | Subacute progressive viral hepatitis (HP:0006572) | 2.17285498 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.16262084 |
| 67 | B lymphocytopenia (HP:0010976) | 2.12364434 |
| 68 | Obstructive lung disease (HP:0006536) | 2.11444316 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11444316 |
| 70 | Persistence of primary teeth (HP:0006335) | 2.11264197 |
| 71 | Pulmonary embolism (HP:0002204) | 2.09541425 |
| 72 | Thyroiditis (HP:0100646) | 2.09245052 |
| 73 | Cellulitis (HP:0100658) | 2.07355933 |
| 74 | Menorrhagia (HP:0000132) | 2.06049264 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.05580859 |
| 76 | IgA deficiency (HP:0002720) | 2.03652960 |
| 77 | Basal cell carcinoma (HP:0002671) | 2.02030730 |
| 78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01689239 |
| 79 | Dislocated radial head (HP:0003083) | 2.01380292 |
| 80 | Widely spaced teeth (HP:0000687) | 2.00254068 |
| 81 | Papillary thyroid carcinoma (HP:0002895) | 2.00253266 |
| 82 | Heterotopia (HP:0002282) | 1.99771749 |
| 83 | Dilatation of the ascending aorta (HP:0005111) | 1.96350467 |
| 84 | Stomach cancer (HP:0012126) | 1.94076188 |
| 85 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.93739638 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91387982 |
| 87 | Acrocyanosis (HP:0001063) | 1.91306348 |
| 88 | Acute hepatic failure (HP:0006554) | 1.87316146 |
| 89 | Verrucae (HP:0200043) | 1.86747538 |
| 90 | Papilloma (HP:0012740) | 1.86747538 |
| 91 | Vertebral arch anomaly (HP:0008438) | 1.86550573 |
| 92 | Osteomyelitis (HP:0002754) | 1.83452263 |
| 93 | Conjunctival telangiectasia (HP:0000524) | 1.83410320 |
| 94 | Arterial thrombosis (HP:0004420) | 1.83061432 |
| 95 | Pulmonary fibrosis (HP:0002206) | 1.82852343 |
| 96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81731851 |
| 97 | Aortic aneurysm (HP:0004942) | 1.81016084 |
| 98 | Acute myeloid leukemia (HP:0004808) | 1.80372580 |
| 99 | Slow saccadic eye movements (HP:0000514) | 1.80323201 |
| 100 | Glomerulopathy (HP:0100820) | 1.75364634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.03066667 |
| 2 | BRD4 | 2.98946832 |
| 3 | TAOK3 | 2.91390873 |
| 4 | RIPK4 | 2.69922467 |
| 5 | MAP4K1 | 2.68269584 |
| 6 | NLK | 2.43448369 |
| 7 | MAP3K14 | 2.29191849 |
| 8 | TYK2 | 2.27915854 |
| 9 | PRPF4B | 2.27446894 |
| 10 | BLK | 2.09770963 |
| 11 | EPHA3 | 2.08454449 |
| 12 | JAK1 | 1.97842618 |
| 13 | ZAP70 | 1.88051127 |
| 14 | FGFR3 | 1.87096242 |
| 15 | CDK12 | 1.84441007 |
| 16 | BCKDK | 1.70991714 |
| 17 | FGFR4 | 1.67607433 |
| 18 | BTK | 1.66495711 |
| 19 | BMPR2 | 1.58198065 |
| 20 | JAK3 | 1.52283254 |
| 21 | SIK3 | 1.49447606 |
| 22 | FES | 1.47201066 |
| 23 | IKBKE | 1.46667989 |
| 24 | SYK | 1.44603842 |
| 25 | CSK | 1.43472910 |
| 26 | ITK | 1.43106966 |
| 27 | TEC | 1.41756698 |
| 28 | GRK6 | 1.36178289 |
| 29 | CAMKK2 | 1.35699131 |
| 30 | HCK | 1.33667551 |
| 31 | MARK3 | 1.30035450 |
| 32 | MAP3K7 | 1.29044652 |
| 33 | EIF2AK3 | 1.26754343 |
| 34 | AKT3 | 1.26029936 |
| 35 | JAK2 | 1.25893683 |
| 36 | MAP3K13 | 1.19364281 |
| 37 | SIK2 | 1.14529115 |
| 38 | LCK | 1.14033405 |
| 39 | IRAK4 | 1.13598262 |
| 40 | MAP3K10 | 1.12363103 |
| 41 | MAPK7 | 1.10949195 |
| 42 | MAP2K3 | 1.07823253 |
| 43 | EPHB1 | 1.07790173 |
| 44 | FRK | 1.02784711 |
| 45 | KSR2 | 1.01318523 |
| 46 | LYN | 1.01120836 |
| 47 | CDK6 | 1.00599668 |
| 48 | MAP3K2 | 0.98837046 |
| 49 | ACVR1B | 0.97827634 |
| 50 | SGK2 | 0.95620153 |
| 51 | CDC42BPA | 0.95051165 |
| 52 | STK10 | 0.93512792 |
| 53 | PASK | 0.91092671 |
| 54 | MAPK11 | 0.90025091 |
| 55 | TBK1 | 0.89353270 |
| 56 | FGR | 0.87562140 |
| 57 | YES1 | 0.87535191 |
| 58 | NEK9 | 0.85338647 |
| 59 | MARK2 | 0.84415639 |
| 60 | TRPM7 | 0.84050073 |
| 61 | KIT | 0.80375328 |
| 62 | PIK3CG | 0.80068898 |
| 63 | IRAK1 | 0.79235931 |
| 64 | CLK1 | 0.78341842 |
| 65 | ERN1 | 0.78000204 |
| 66 | RET | 0.77880448 |
| 67 | PDGFRB | 0.75116715 |
| 68 | IKBKB | 0.74384268 |
| 69 | MAP3K6 | 0.73538133 |
| 70 | ERBB3 | 0.72947407 |
| 71 | SGK3 | 0.71995242 |
| 72 | TGFBR2 | 0.70465869 |
| 73 | PIM1 | 0.69055666 |
| 74 | CAMKK1 | 0.67743369 |
| 75 | WNK1 | 0.66206046 |
| 76 | KSR1 | 0.64837167 |
| 77 | MELK | 0.64795525 |
| 78 | CDK4 | 0.62546058 |
| 79 | BRSK2 | 0.60005937 |
| 80 | HIPK2 | 0.57358815 |
| 81 | RAF1 | 0.56826530 |
| 82 | PKN2 | 0.54545986 |
| 83 | SGK223 | 0.54132072 |
| 84 | SGK494 | 0.54132072 |
| 85 | MAP3K1 | 0.54015967 |
| 86 | PDK1 | 0.54003874 |
| 87 | MAPK12 | 0.52989165 |
| 88 | TNK2 | 0.48971555 |
| 89 | CSF1R | 0.48310683 |
| 90 | ICK | 0.47564962 |
| 91 | ABL1 | 0.45759170 |
| 92 | PRKCQ | 0.45505856 |
| 93 | LATS1 | 0.45002141 |
| 94 | MKNK2 | 0.44196376 |
| 95 | CAMK4 | 0.42941045 |
| 96 | GRK7 | 0.40733997 |
| 97 | PDGFRA | 0.40078658 |
| 98 | SGK1 | 0.38740622 |
| 99 | CHUK | 0.37912792 |
| 100 | STK38 | 0.37540408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.28460245 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22237676 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15615325 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14717705 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12848685 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.10959080 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.99484958 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94461373 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90992632 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89875290 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84499456 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81913422 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.74881126 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73473544 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72550835 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69874023 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69627639 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54677402 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53146670 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48540999 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48178726 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47459269 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39308068 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38678598 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.38203993 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37962912 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.35174064 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.33470219 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33442196 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32606763 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30671682 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30589149 |
| 33 | Colorectal cancer_Homo sapiens_hsa05210 | 1.28964901 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27346951 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.25611744 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24753775 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23508267 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22024464 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16089146 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.13473848 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.11655266 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.10995664 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.09780667 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08357926 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06758382 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06705423 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.04509442 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98160537 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.95636985 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94930663 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94313384 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.94001258 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.91130487 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89659076 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89388608 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88703128 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87614845 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.87031827 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83986311 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82785330 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81785804 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78432152 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75742032 |
| 64 | Prostate cancer_Homo sapiens_hsa05215 | 0.73114341 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72893579 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72755056 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71629593 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.71056052 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68673508 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68614351 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68540234 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67162440 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63607794 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.63330584 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60519390 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59708497 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59619074 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.58636855 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58161525 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57485018 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.57313421 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56650254 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53128358 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52035025 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51110639 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.51031336 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.50190709 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49508549 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48329048 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.47578446 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47230566 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45997134 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45773744 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.44548758 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44383639 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.42295478 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42221087 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42104091 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41072867 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40784506 |

